Enlightenment Pharmaceutical (000590.SZ): Hengyang State-owned Assets Administration Commission plans to transfer 5.84% of the shares to Hongxiang Group free of charge

Gelonghui, May 7, 丨 Enlightenment Pharmaceutical (000590.SZ) announced that it recently received the “Notice on the Free Transfer of Enlightenment Pharmaceutical Shares” from the Hengyang Municipal People's Government State-owned Assets Supervision and Administration Committee (“Hengyang State-owned Assets Administration Commission”), the third largest shareholder. The main content of the notice is that the Hengyang Municipal State-owned Assets Administration Commission decided to transfer the 13,988,705 shares of the Company with unlimited sales conditions (5.84% of the company's total share capital) to Hengyang Hongxiang State-owned Investment (Holdings) Group Co., Ltd. (“Hongxiang Group”) free of charge. After the implementation of this free transfer of state-owned shares is completed, Hongxiang Group will maintain

Gelonghui FinanceMay 7 06:00 ET

Enlightenment Pharmaceutical (000590.SZ) announced first-quarter results with a net loss of 8.2843 million yuan

Enlightenment Pharmaceutical (000590.SZ) released its report for the first quarter of 2024, achieving 770 operating income during the reporting period...

Zhitong FinanceApr 25 05:39 ET

Additional Considerations Required While Assessing Tus-Pharmaceutical Group's (SZSE:000590) Strong Earnings

Tus-Pharmaceutical Group Co., Ltd.'s (SZSE:000590) stock was strong after they recently reported robust earnings. We did some analysis and think that investors are missing some details hidden beneath

Simply Wall StApr 3 19:14 ET

Enlightenment Pharmaceutical (000590.SZ) announced its 2023 annual results, net profit of 25.2468 million yuan, an increase of 39.41%

Enlightenment Pharmaceutical (000590.SZ) released its 2023 annual report. The company's revenue was 405 million yuan...

Zhitong FinanceMar 27 07:49 ET

Optimistic Investors Push Tus-Pharmaceutical Group Co., Ltd. (SZSE:000590) Shares Up 32% But Growth Is Lacking

Tus-Pharmaceutical Group Co., Ltd. (SZSE:000590) shareholders are no doubt pleased to see that the share price has bounced 32% in the last month, although it is still struggling to make up recently lo

Simply Wall StMar 18 19:15 ET

Enlightenment Pharmaceutical (000590.SZ): Net profit is expected to increase by 32.26%-65.33% year-on-year in 2023

On January 30, Gelonghui Pharmaceutical (000590.SZ) announced that it expects net profit of 24 million yuan to 30 million yuan in 2023, an increase of 32.26% to 65.33% over the same period last year, after deducting a loss of 6 million yuan - a profit of 1 million yuan. The increase in net profit attributable to shareholders of listed companies in 2023 over the same period of the previous year was mainly due to non-recurring profit and loss, mainly including: the company confirmed compensation income for land occupied by the government due to public infrastructure construction, the original shareholders of the subsidiary Guangdong Xiantong Pharmaceutical Co., Ltd. needed to pay compensation to the company, and confirmation of government subsidy income

Gelonghui FinanceJan 30 04:26 ET